Skip to main content
SpringerLink
Log in

No increase in HF risk or mortality with thiazolidinediones

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Aguilar D, Bozkurt B, Pritchett A, Petersen NJ, Deswal A.The impact of thiazolidinedione use on outcomes in ambulatory patients with diabetes mellitus and heart failure. Journal of the American College of Cardiology 50: 32-36, No. 1, 3 Jul 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

No increase in HF risk or mortality with thiazolidinediones. React. Wkly. 1160, 1 (2007). https://doi.org/10.2165/00128415-200711600-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711600-00001

Keywords

Search

Navigation